Cribado de enfermedad pulmonar intersticial difusa en pacientes con artritis reumatoide: una revisión sistemática

• Garrote-Corral, Sandra ; Silva-Fernández, Lucía ; Seoane-Mato, Daniel ; Guerra-Rodríguez, Mercedes ^[1] ; Aburto, Myriam ; Castañeda, Santos ; Valenzuela, Claudia ; Narváez, Javier
  1. [1] Unidad de Investigación, Sociedad Española de Reumatología, Madrid, España
• Localización: Reumatología clínica, ISSN 1699-258X, Vol. 18, Nº. 10, 2022, págs. 587-596
• Idioma: español
• Títulos paralelos:
  • Screening of interstitial lung disease in patients with rheumatoid arthritis: A systematic review
• Texto completo no disponible (Saber más ...)
• Resumen

  • Aims Interstitial lung disease (ILD) is frequent in patients with rheumatoid arthritis (RA) and is associated with significant morbidity and mortality. The aim of this review was to identify the different screening methods for ILD in patients with RA.

    Methods We ran a systematic search in Pubmed, Embase and Cochrane Library up to April 2020 and did a hand search of the references of the retrieved articles. The search was limited to humans and articles published in English, Spanish or French. We selected studies with any design where: a) the population included adult patients with RA; b) the intervention was any screening method for ILD; and c) validity or reliability of the screening method were evaluated, or a screening method was described. Two reviewers independently screened the articles by title and abstract and subsequently extracted the information using a specific data extraction form.

    Results 25 studies were included with a total of 2,593 patients. The most frequently used tool for ILD screening was high resolution computed tomography (HRCT) of the lung. Electronic auscultation, biochemical markers, bronchoalveolar lavage (BAL), pulmonary function tests (PFTs) and lung ultrasonography were also evaluated. Across the different studies, electronic auscultation and lung ultrasonography achieved higher accuracy than PFTs, BAL and biochemical markers.

    Conclusions HRCT resulted as the most sensitive tool for ILD screening in patients with RA. Given its harmlessness and high sensitivity, lung ultrasonography may become the first-choice tool in the future.